First Time Loading...

Adaptimmune Therapeutics PLC
NASDAQ:ADAP

Watchlist Manager
Adaptimmune Therapeutics PLC Logo
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Watchlist
Price: 1.15 USD -1.71%
Updated: May 15, 2024

Adaptimmune Therapeutics PLC
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adaptimmune Therapeutics PLC
Pre-Tax Income Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Pre-Tax Income
-$112.5m
CAGR 3-Years
5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Pre-Tax Income
-$176.1m
CAGR 3-Years
-155%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Pre-Tax Income
-$208.4m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Pre-Tax Income
-$166.4m
CAGR 3-Years
-43%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Pre-Tax Income
-£60.9m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Pre-Tax Income
£38.7m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
2%

See Also

What is Adaptimmune Therapeutics PLC's Pre-Tax Income?
Pre-Tax Income
-112.5m USD

Based on the financial report for Dec 31, 2023, Adaptimmune Therapeutics PLC's Pre-Tax Income amounts to -112.5m USD.

What is Adaptimmune Therapeutics PLC's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-3%

Over the last year, the Pre-Tax Income growth was 31%. The average annual Pre-Tax Income growth rates for Adaptimmune Therapeutics PLC have been 5% over the past three years , -3% over the past five years .